About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Phase 3 Clinical Study of KHK 4827 | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT02052609

A Phase 3 Clinical Study of KHK 4827

This study is designed to evaluate the safety and efficacy of long-term exposure to KHK4827 in subjects with plaque psoriasis (psoriasis vulgaris, psoriatic erythroderma) who have completed Study 4827...

Lead sponsor: Kyowa Kirin Co., Ltd.•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Kyowa Kirin Co., Ltd.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Subject has voluntarily signed the written informed consent form to participate in this study
•Subject has completed the week 52 evaluation either in Study 003 or 004

Exclusion Criteria

•Subject has had a serious infection, defined as requiring systemic treatment with antibiotics or antivirals (excluding oral administration)
•Subject has been judged to be ineligible for participation in the study by the investigators/sub investigators

Related studies

RECRUITINGPhase 2

Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

NCT07486960 · Psoriatic Arthritis

Oxidative Stress in Autoimmune Rheumatic Diseases

NCT07536529 · Inflammatory Joint Diseases, Rheumatoid Arthritis (RA), and more

RECRUITINGPhase 2/3

A Study of Picankibart in Patients With Active Psoriatic Arthritis

NCT07295509 · Psoriatic Arthritis

RECRUITINGPhase 3

Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

NCT07286058 · Psoriatic Arthritis

RECRUITINGPhase 4

Proactive TDM Versus Standard Use of Biologics in Psoriasis

NCT06398106 · Psoriasis Vulgaris

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 25, 2023Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment155

Start dateFeb 2014

Last updatedAug 25, 2023

Condition

Psoriasis Vulgaris Psoriatic Arthritis Pustular; Psoriasis, Palmaris Et Plantaris Psoriatic Erythroderma

Locations shown

For additional information regarding investigative sites for this trial, contact Kyowa Kirin

Chiyoda-ku, Tokyo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 25, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions